Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin/hypocretin receptor signalling cascades
Jyrki P. Kukkonen, Christopher S. Leonard
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 314-331
Open Access | Times Cited: 180

Showing 1-25 of 180 citing articles:

The role of orexin in motivated behaviours
Takeshi Sakurai
Nature reviews. Neuroscience (2014) Vol. 15, Iss. 11, pp. 719-731
Closed Access | Times Cited: 414
Motivational activation: a unifying hypothesis of orexin/hypocretin function
Stephen V. Mahler, David E. Moorman, Rachel J. Smith, et al.
Nature Neuroscience (2014) Vol. 17, Iss. 10, pp. 1298-1303
Open Access | Times Cited: 358
The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Chunmei Wang, Qinqin Wang, Bingyuan Ji, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 163
Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71
Orexin/hypocretin role in reward: implications for opioid and other addictions
Corey Baimel, Selena E. Bartlett, Lih‐Chu Chiou, et al.
British Journal of Pharmacology (2014) Vol. 172, Iss. 2, pp. 334-348
Open Access | Times Cited: 168
Projection-Target-Defined Effects of Orexin and Dynorphin on VTA Dopamine Neurons
Corey Baimel, Benjamin K. Lau, Min Qiao, et al.
Cell Reports (2017) Vol. 18, Iss. 6, pp. 1346-1355
Open Access | Times Cited: 128
Orexin/hypocretin receptor signalling: a functional perspective
Christopher S. Leonard, Jyrki P. Kukkonen
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 294-313
Open Access | Times Cited: 126
Orexins and fear: implications for the treatment of anxiety disorders
África Flores, Rocío Saravia, Rafaël Maldonado, et al.
Trends in Neurosciences (2015) Vol. 38, Iss. 9, pp. 550-559
Open Access | Times Cited: 92
Orexin prevents depressive-like behavior by promoting stress resilience
Miao‐Jin Ji, Xiaoyang Zhang, Zi Chen, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 2, pp. 282-293
Open Access | Times Cited: 80
Orexin receptors exert a neuroprotective effect in Alzheimer’s disease (AD) via heterodimerization with GPR103
Julie Davies, Jing Chen, Ryan Pink, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 69
Orexin/Hypocretin Signaling
Jyrki P. Kukkonen
Current topics in behavioral neurosciences (2016), pp. 17-50
Open Access | Times Cited: 67
Regulation of Lateral Hypothalamic Orexin Activity by Local GABAergic Neurons
Loris L. Ferrari, Daniel Park, Lin Zhu, et al.
Journal of Neuroscience (2018) Vol. 38, Iss. 6, pp. 1588-1599
Open Access | Times Cited: 65
Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in iP rats
Robyn M. Brown, Andrezza K. Kim, Shaun Yon‐Seng Khoo, et al.
Addiction Biology (2015) Vol. 21, Iss. 3, pp. 603-612
Open Access | Times Cited: 64
<p>Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications</p>
Min Gong, Song Wen, Thiquynhnga Nguyen, et al.
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 943-962
Open Access | Times Cited: 64
New Aspects of Corpus Luteum Regulation in Physiological and Pathological Conditions: Involvement of Adipokines and Neuropeptides
Ewa Mlyczyńska, Marta Kieżun, Patrycja Kurowska, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 957-957
Open Access | Times Cited: 36
Physiological Role of Orexinergic System for Health
Ines Villano, Marco La Marra, Girolamo Di Maio, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 14, pp. 8353-8353
Open Access | Times Cited: 33
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Orexin receptor antagonists in the pathophysiology and treatment of sleep disorders and epilepsy
Mohammad Sheibani, Maryam Shayan, Mina Khalilzadeh, et al.
Neuropeptides (2023) Vol. 99, pp. 102335-102335
Closed Access | Times Cited: 18
Transient targeting of hypothalamic orexin neurons alleviates seizures in a mouse model of epilepsy
Han‐Tao Li, Paulius Viskaitis, Edward F. Bracey, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far
África Flores, Rafaël Maldonado, Fernando Berrendero
Frontiers in Neuroscience (2013) Vol. 7
Open Access | Times Cited: 63
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
Miles D. Thompson, Henri Xhaard, Takeshi Sakurai, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 61
Hypothalamic neuropeptide signaling in alcohol addiction
Jessica R. Barson, Sarah F. Leibowitz
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015) Vol. 65, pp. 321-329
Open Access | Times Cited: 54
Role of orexin type-1 receptors in paragiganto-coerulear modulation of opioid withdrawal and tolerance: A site specific focus
S. Mohammad Ahmadi‐Soleimani, Hossein Azizi, Heinrich S. Gompf, et al.
Neuropharmacology (2017) Vol. 126, pp. 25-37
Open Access | Times Cited: 54
Distribution of the orexin-1 receptor (OX1R) in the mouse forebrain and rostral brainstem: A characterisation of OX1R-eGFP mice
Sarah S. Ch’ng, Andrew J. Lawrence
Journal of Chemical Neuroanatomy (2015) Vol. 66-67, pp. 1-9
Closed Access | Times Cited: 52
Structure-based development of a subtype-selective orexin 1 receptor antagonist
Jan Hellmann, Matthäus Drabek, Jie Yin, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 30, pp. 18059-18067
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top